Chang Liu, MPH; Devinder Dhindsa, MD; Zakaria Almuwaqqat, MD, MPH; et al.
free access
JAMA Cardiol. 2022;7(7):672-680. doi:10.1001/jamacardio.2022.0912
This cohort study investigates the association between very high high-density lipoprotein cholesterol (HDL-C) level and outcomes in patients with coronary artery disease.
M. Cecilia Bahit, MD; Amit N. Vora, MD, MPH; Zhuokai Li, PhD; et al.
free access
JAMA Cardiol. 2022;7(7):682-689. doi:10.1001/jamacardio.2022.1166
This randomized clinical trial analyzes data comparing treatment regimens according to prior stroke, transient ischemic attack, or thromboembolism to determine the safety and efficacy of apixaban, vitamin K antagonists, and aspirin.
Fiona Dee, RN; Lindsay Savage, RN; James W. Leitch, MBBS; et al.
open access
JAMA Cardiol. 2022;7(7):690-698. doi:10.1001/jamacardio.2022.1188
This randomized clinical trial seeks to improve outcomes of ST-segment elevation myocardial infarction in rural areas in Australia by reducing missed diagnoses and increasing administration of primary reperfusion therapy.
Caroline Hauw-Berlemont, MD, MS; Lionel Lamhaut, MD, PhD; Jean-Luc Diehl, MD; et al.
free access
JAMA Cardiol. 2022;7(7):700-707. doi:10.1001/jamacardio.2022.1416
This randomized clinical trial investigates the use of emergency coronary angiogram vs delayed coronary angiogram in patients who experience out-of-hospital cardiac arrest without ST-segment elevation.
Andrew S. Oseran, MD, MBA; Tianyu Sun, PhD; Rishi K. Wadhera, MD, MPP, MPhil
free access
JAMA Cardiol. 2022;7(7):708-714. doi:10.1001/jamacardio.2022.1282
This cross-sectional study evaluates insurance coverage, health care access, and management of cardiovascular risk factors among working-age adults with low income by state Medicaid expansion status and individuals鈥 insurance status.
Kiran J. Biddinger; Sean J. Jurgens, BSc; Dimitri Maamari, MD; et al.
free access
JAMA Cardiol. 2022;7(7):715-722. doi:10.1001/jamacardio.2022.1061
This cohort study examines data from the UK Biobank and Mass General Brigham Biobank to assess the contribution of rare and common genetic variants to risk of hypertrophic cardiomyopathy in the general population.
Aniruddh P. Patel, MD; Jacqueline S. Dron, PhD; Minxian Wang, PhD; et al.
free access
has audio
JAMA Cardiol. 2022;7(7):723-732. doi:10.1001/jamacardio.2022.0901
This genetic association study investigates the association of pathogenic DNA variants implicated in inherited cardiomyopathy with cardiovascular disease outcomes and all-cause mortality.
-
Podcast:
Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes
Zachary T. Yoneda, MD, MSCI; Katherine C. Anderson, ScM, CGC; Fei Ye, PhD; et al.
open access
has audio
JAMA Cardiol. 2022;7(7):733-741. doi:10.1001/jamacardio.2022.0810
This cohort study assesses the association of rare variants of cardiomyopathy and arrhythmia genes with all-cause mortality among patients with early-onset atrial fibrillation.
-
Podcast:
Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes